New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 11, 2014
05:35 EDTNXTMNxStage Medical downgraded to Underperform from Market Perform at Wells Fargo
Wells Fargo downgraded NxStage Medical to Underperform on concern the company's plans to 10-15 dialysis centers in the U.S. by the end of 2014 will not significantly increase the number of home hemodialysis patients and may put in-center revenue at risk. Wells lowered its price target range for shares to $10-$12 from $11-$14.
News For NXTM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 12, 2014
12:40 EDTNXTMNxStage Medical management to meet with Leerink
Subscribe for More Information
November 11, 2014
07:09 EDTNXTMNxStage Medical to present positive results from NxStage home hemodialisys study
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use